ABSTRACT Cardiovascular function was studied in anaesthetised male rats which received 50 ,ug/ml of arsenic (as sodium arsenate) in deionised drinking water for 320 days. High urinary excretion of arsenic was found at the end of treatment and the metal accumulated considerably in the kidneys and liver, which both presented slight alterations. No histopathological modifications were evident in other organs. Base line blood pressure, cardiac inotropism, and chronotropism and cardiovascular reactivity to noradrenaline, acetylcholine, angiotensin II, bradykinin, histamine, and serotonin did not differ in exposed or in control animals. In the exposed group, however, there was potentiation of the effects of vascular beta-adrenoceptor stimulation and a reduction in the vascular responsiveness to angiotensin I. Chronic arsenic exposure did not affect the baroreflex sensitivity but was able to induce sympathetic hyperactivity or hypersensitivity, or both, possibly associated with an antivagal action. Our results might help to explain the cardiovascular alterations seen in people chronically exposed to high concentrations of arsenic.
Chronic arsenic exposure may induce alterations of the cardiovascular system, ranging from electrocardiographic changes to infarction' 3 and from arteriosclerosis, Raynaud's syndrome, and acrocyanosis to thromboangioitis obliterans and gangrene in the feet.47 Epidemiological investigations89 suggest that occupational arsenic exposure increases the incidence of mortality from cardiovascular disease. The extent of the cardiovascular injuries seems to depend on the nature of exposure, subjects, geographical area, and level of metal intake.410-12 There is also general agreement that electrocardiographic changes (prolongation of the Q-T interval, abnormal T-waves, lengthening of the S-T segment) occur before the appearance of irreversible vascular and cardiac alterations (swelling and proliferation of the endothelium, thickening and hyalinisation of the wall, thrombosis of peripheral and coronary vessels).'3-'5 The mechanisms by which chronic arsenic exposure induces cardiovascular alterations are poorly understood, and little information is available regarding the cardiovascular effects of arsenic exposure on experimental animals,'6 although it has been reported that cats receiving either arsenite or arsenate in their feed showed electrocardiographic changes. ' 20 The heart rate was obtained with a cardiotachometer coupler triggered by the R-peak of the electrocardiogram recorded from standard lead II. Heart rate, dP/dt max, and ECG were continuously monitored on the same poligraph recorder. The animals were breathing spontaneously, and a stabilisation period of 30 minutes was observed after the accomplishment of the surgical procedures.
The experimental protocol included: (a) evaluation of the cardiovascular parameters in basal conditions; (b) occlusion of the common carotid arteries for 30 seconds2'; (c) intravenous injection of noradrenaline (1 ,ug/kg), adrenaline (0.125, 0-5, and 1 gg/kg), acetylcholine (1.25 ,ug/kg), angiotensin I (0.5 ,ug/kg), angiotensin II (0-5 ,ug/kg), bradykinin (1.5 ,ug/kg), histamine (5 ,ug/kg), and serotonin (5 ,ug/kg); (d) bilateral selective vagotomy carried out at the neck below the nodose ganglion; and (e) intravenous injection of graduated doses of hexamethonium (0-625, 1*25, and 2-5 mg/kg). Each consecutive test was not performed until the parameters returned to the values preceding the bilateral carotid occlusion and remained stable. All doses were expressed as the free base and peak effects were considered for each assay. Drugs were dissolved in 0-9% saline and solutions were kept in glassstoppered tubes at 2-40C and protected from light to prevent oxidation. The stability of the solutions was ascertained by the rat blood pressure assay. Solutions were injected in a volume of 25 ,u1 over a period of three seconds and flushed in with 50 ,ul of 0-9% saline. The administration of solvents caused insignificant changes in the cardiovascular parameters.
DETERMINATION OF ARSENIC
The arsenic content of 24 hour urines and of liver, kidney, brain, and gastrocnemius muscle were determined by atomic absorption spectrophotometry after wet acid digestion, using a procedure similar to that described by Orheim The animals exposed to arsenic showed base-line blood pressure, dP/dt max (table 1), and heart rate no different from those observed in the control group. Similarly, no difference was shown in the electrocardiographic patterns of both treated and untreated rats. Also the reactivity of the baroreflex arc, tested by bilateral carotid occlusion, did not change after chronic exposure to arsenic (table 1) .
The experiments performed to evaluate possible effects of the metal on the cardiovascular responsiveness to some neurohumoral agonists showed that chronic arsenic exposure did not influence the cardiovascular responses to noradrenaline, acetylcholine, angiotensin II, bradykinin, histamine, and serotonin. In arsenic exposed rats, however, the systolic hypertensive and the diastolic hypotensive responses to adrenaline were, respectively, reversed and increased when the amine was given at the dose of 0-125 A.g/kg (known to be provided with prevalent beta-adrenoceptor stimulating effects) (fig). On the other hand, the pressor responses to 1 and 2 ,ug/kg of adrenaline (depending on a predominant stimulation of the vascular alpha-adrenoceptors)
were unchanged in the arsenic exposed animals. It should be pointed out that neither inotropic nor chronotropic responses to all doses of adrenaline 
At the end of the experiment, urinary arsenic concentrations were 63-4 + 8-1 ,ug/l (mean SEM) in the control group and 23 274 + 2942 1ug/ in the exposed animals. In the treated rats arsenic accumulated in the brain and in the muscles, but greater accumulation of the metal was found in the kidney and in the liver (table 2) .
HISTOPATHOLOGICAL STUDY
No alterations were found in the myocardium or in the gastrocnemius muscle, in the arterial vessels, in the lungs, in the brain, and in the sciatic nerves. The in control (open bars) and arsenic-exposed male rats (hatched bars). All values are means SEM (n = 10 in both groups). * p < 0-01 and ** p < 0-001 indicate significantly different from control. Table 2 Arsenic content in different organs ofarsenic-exposed male ratst r liver of the exposed rats showed a normal lobular structure, but swollen hepatocytes were evident near the centrilobular veins. The kidneys of the treated rats showed glomerular and tubular alterations of a focal type. Glomerular capillaries were enlarged with the mesangial matrix thickened in small areas. Erythrocytes were evidenced in the tubular lumen, while haemosiderin granules were observed in the cytoplasm of epithelial cells of proximal tubules. Casts of amorphous hyaline material filled some tubules.
Discussion
In this study we exposed the animals to pentavalent arsenic, which is thought to be less toxic than the trivalent form,'8 although trivalent arsenic may be transformed in vivo to pentavalent arsenic,24 and the inverse transformation is also thought to be possible. 25 The high concentration of urinary arsenic found in the exposed rats confirms reports26 that inorganic arsenic is almost completely absorbed from the gastrointestinal tract. Our study also confirms that rats exposed to sodium arsenate accumulate arsenic in the tissues, by contrast with other laboratory animals and with man. 2728 The liver and kidneys were the only organs of the exposed rats to show histopathological lesions. The observed tubular damage may depend on the high urinary excretion of arsenic or on the competitive antagonism by which this element opposes the reabsorption of phosphate, or both.2429 On the other hand, the glomerular lesions found in the exposed rats seem to emphasise a specific toxic action of arsenic on glomerular capillaries, since we did not observe alterations in the aorta or in other arteries. These glomerular lesions may also account for the erythrocytes and the haemosiderin granules which were observed in the tubular lumen and in the tubular epithelium respectively.
The absence of changes in the ECG, in the blood pressure, in cardiac inotropism and chronotropism, and the lack of histopathological alterations in the heart and in the arterial vessels of the exposed animals is in agreement with previous observations on rats chronically exposed to sodium arsenite.'8 On the other hand, the cardiovascular responses observed in the exposed rats, after either vagotomy or administration of the higher doses of hexamethonium (given after vagotomy), appear to suggest a shift towards a sympathetic hypersensitivity or hyperactivity or both. The results obtained after vagotomy alone, however, do not exclude a possible antivagal action of the arsenic. The pressor, inotropic, and chronotropic responses to bilateral carotid occlusion did not differ in the two groups of rats so that it may be thought that the baroreflex mechanisms do not influence the cardiovascular reactivity to the sympathetic stimulation. Moreover, the cardiovascular reactivity to various physiological receptor agonists such as adrenaline, acetylcholine, angiotensin II, bradykinin, histamine, and serotonin) was not modified by the exposure. Conversely, the reversal of the slight systolic hypertension and the increase of the slight diastolic hypotension observed in the exposed rats after the administration of adrenaline in a dose of 0 
